1. A method of treatment of malaria comprising administering to an individual who has been diagnosed with and/or is suffering from malaria comprising administering to the individual a therapeutically effective amount of a composition comprising one of more compounds of the following formula:wherein:M is Mn or Re,
L is a neutral, two-electron donor ligand,
R1 is an amine-substituted alkyl group,
R2 is H, (CH2)nCH3, wherein n is 0 or any integer from 1 to 20, OMe, OEt, OPh, Ph, CHO, COMe, COPh, CH2OH, CO2H, CO2Me, CO2Et, CH2Ph, NH2, NMe2, NEt2, C6H4Me, C6H4OMe, NH2COMe, F, Cl, Br, or I; and
E is a linker moiety connecting the cyclopentadienyl moiety with the chloroquinoline moiety, wherein E is NH(CH2)n, NH(CH2)nNH, or NH(CH2)nNH(CH2) and n is an integer from 1 to 10.